Comment diagnostiquer une infection par coronavirus ?

Le diagnostic se fait par PCR sur un échantillon respiratoire ou sérique.

Quels tests sont utilisés pour détecter le SARS-CoV-2 ?

Les tests PCR et les tests antigéniques sont couramment utilisés.

Les anticorps peuvent-ils indiquer une infection passée ?

Oui, la présence d'anticorps spécifiques indique une infection antérieure.

Quels symptômes sont surveillés lors du diagnostic ?

Fièvre, toux, essoufflement et fatigue sont des symptômes clés.

Les tests de dépistage sont-ils fiables ?

Les tests PCR sont très fiables, mais les tests antigéniques peuvent avoir des faux négatifs.

Quels sont les symptômes courants du COVID-19 ?

Fièvre, toux sèche, fatigue, perte de goût ou d'odorat, douleurs musculaires.

Les symptômes varient-ils selon les variants ?

Oui, certains variants peuvent provoquer des symptômes différents ou plus graves.

Les enfants présentent-ils des symptômes différents ?

Les enfants peuvent avoir des symptômes plus légers, mais des cas graves existent.

Quels symptômes nécessitent une hospitalisation ?

Difficulté à respirer, douleur thoracique persistante, confusion, lèvres ou visage bleu.

Peut-on avoir des symptômes prolongés après l'infection ?

Oui, certains patients présentent des symptômes persistants, appelés COVID long.

Quelles sont les mesures préventives contre le COVID-19 ?

Port du masque, distanciation sociale, lavage des mains et vaccination.

La vaccination est-elle obligatoire ?

La vaccination n'est pas obligatoire, mais fortement recommandée pour la protection.

Comment se protéger des variants ?

Suivre les recommandations de santé publique et se faire vacciner régulièrement.

Les masques sont-ils efficaces ?

Oui, les masques réduisent la transmission du virus, surtout en milieu clos.

Quelles sont les recommandations pour les rassemblements ?

Limiter les rassemblements, surtout en intérieur, et respecter les mesures sanitaires.

Quels traitements sont disponibles pour le COVID-19 ?

Les traitements incluent les antiviraux, les corticostéroïdes et l'oxygénothérapie.

Les vaccins sont-ils efficaces contre les variants ?

Les vaccins offrent une protection, mais leur efficacité peut varier selon le variant.

Quels médicaments sont utilisés pour les cas graves ?

Les cas graves peuvent nécessiter des traitements comme le remdesivir ou des anticorps monoclonaux.

Les traitements préventifs existent-ils ?

Oui, des traitements préventifs comme les anticorps monoclonaux sont disponibles.

Comment la réhabilitation aide-t-elle après COVID-19 ?

La réhabilitation aide à récupérer la fonction pulmonaire et à gérer les symptômes persistants.

Quelles sont les complications possibles du COVID-19 ?

Pneumonie, syndrome de détresse respiratoire aiguë, thromboses et complications neurologiques.

Le COVID-19 peut-il affecter le cœur ?

Oui, des complications cardiaques comme la myocardite peuvent survenir.

Les complications sont-elles plus fréquentes chez les personnes âgées ?

Oui, les personnes âgées et celles avec des comorbidités sont à risque accru.

Quelles sont les complications neurologiques possibles ?

Des AVC, des troubles de l'odorat et des problèmes cognitifs peuvent survenir.

Le COVID long est-il une complication reconnue ?

Oui, le COVID long est une complication reconnue avec des symptômes persistants.

Quels sont les principaux facteurs de risque ?

Âge avancé, maladies chroniques, obésité et immunodépression augmentent le risque.

Les fumeurs sont-ils plus à risque ?

Oui, le tabagisme augmente le risque de complications respiratoires graves.

Les personnes atteintes de diabète sont-elles plus vulnérables ?

Oui, le diabète est un facteur de risque majeur pour des formes graves de COVID-19.

Les femmes enceintes sont-elles à risque accru ?

Les femmes enceintes peuvent avoir un risque accru de complications, surtout si elles ont des comorbidités.

Les personnes vivant en milieu urbain sont-elles plus exposées ?

Oui, la densité de population et la transmission communautaire augmentent le risque.

Coronaviridae - Informations médicales vérifiées

Associations between muscle morphology and spasticity in children with spastic cerebral palsy.

May 2023

DOI: 10.1016/j.ejpn.2023.01.007 PMID: 36706682

Due to the heterogeneous clinical presentation of spastic cerebral palsy (SCP), which makes spasticity treatment challenging, more insight into the complex interaction between spasticity and altered m... We studied associations between spasticity and muscle morphology and compared muscle morphology between commonly observed spasticity patterns (i.e. different muscle activation patterns during passive ... Spasticity and muscle morphology of the medial gastrocnemius (MG) and semitendinosus (ST) were defined in 74 children with SCP (median age 8 years 2 months, GMFCS I/II/III: 31/25/18, bilateral/unilate... A moderate negative association (r = -0.624, p < 0.001) was found between spasticity and MG muscle volume, while other significant associations between spasticity and muscle morphology parameters were... Higher spasticity levels were associated with smaller MG and ST volumes and shorter MG muscles. These muscle morphology alterations were more pronounced in muscles that activated during low-velocity s...

Humans Child Cerebral Palsy Muscle Spasticity Muscle, Skeletal +1 autres

Efficacy of nabiximols oromucosal spray on spasticity in people with multiple sclerosis: Treatment effects on Spasticity Numeric Rating Scale, muscle spasm count, and spastic muscle tone in two randomized clinical trials.

Jul 2023

DOI: 10.1016/j.msard.2023.104745 PMID: 37209500

To provide a comprehensive assessment of the treatment effects of nabiximols oromucosal spray on multiple sclerosis spasticity in two clinical trials, GWSP0604 and SAVANT.... Both studies enriched for responders before randomization, defined by a ≥20% improvement in Spasticity 0-10 numeric rating scale (NRS) score. Additionally, SAVANT used randomized re-titration followin... Mean change from baseline in average daily Spasticity NRS scores was significantly larger for nabiximols than placebo at all postbaseline timepoints, ranging from -0.36 to -0.89 in GWSP0604 and -0.52 ... Nabiximols leads to improvement in spasticity that was sustained over the 12-week treatment period as measured by average daily Spasticity NRS scores, daily spasm counts, and MAS scores for combinatio...

Humans Cannabidiol Dronabinol Drug Combinations Multiple Sclerosis +4 autres

Rebalancing the Spastic Wrist by Transposition of Antagonistic Muscle-Tendon Complex.

01 Jun 2022

DOI: 10.1097/BTH.0000000000000371 PMID: 34711790

Upper limb spasticity and spasticity-induced deformities after upper motor neuron lesions because of traumatic brain injury, encephalitis or cerebral palsy inhibit activities of daily living, result i...

Activities of Daily Living Humans Muscle Spasticity Muscle, Skeletal Tendon Transfer +3 autres

Methods of muscle spasticity assessment in children with cerebral palsy: a scoping review.

11 Jul 2024

DOI: 10.1186/s13018-024-04894-7 PMID: 38992701

Evaluating muscle spasticity in children with cerebral palsy (CP) is essential for determining the most effective treatment strategies. This scoping review assesses the current methods used to evaluat... A search (to April 2024) used keywords such as muscle spasticity, cerebral palsy, and assessment methods. Selection criteria included articles involving CP children, assessing spasticity objectively/s... From an initial pool of 1971 articles, 30 met our inclusion criteria. These studies collectively appraised a variety of techniques ranging from well-established clinical scales like the modified Ashwo... The review discussed the strengths and limitations of each method and concluded that more reliable methods are needed to measure the level of muscle spasticity more accurately....

Humans Muscle Spasticity Cerebral Palsy Child Reproducibility of Results +2 autres

Focal muscle spasticity has little impact on muscle power for walking in people with Traumatic Brain Injury.

07 2023

DOI: 10.1016/j.clinbiomech.2023.105978 PMID: 37295342

Spasticity is prevalent following Traumatic Brain Injury. 'Focal' muscle spasticity has been defined as spasticity affecting a localised muscle group, but it's impact on gait kinetics remains unclear.... Ninety-three participants attending physiotherapy for mobility limitations following Traumatic Brain Injury were invited to participate in the study. Participants underwent clinical gait analysis and ... Hip extensor power generation at initial contact, hip flexor power generation at terminal stance, and knee extensor power absorption at terminal stance were all significantly increased, and ankle powe... Focal muscle spasticity had little association with abnormal gait kinetics in this cohort of independently ambulant people with Traumatic Brain Injury....

Humans Muscle Spasticity Walking Gait Brain Injuries, Traumatic +2 autres

Measuring Mechanical Properties of Spastic Muscles After Stroke. Does Muscle Position During Assessment Really Matter?

12 2022

DOI: 10.1016/j.apmr.2022.05.012 PMID: 35724753

To investigate the influence of muscle position (relaxed vs stretched) on muscle mechanical properties and the ability of myotonometry to detect differences between sides, groups, and sites of testing... Cross-sectional study.... Outpatient rehabilitation units including private and public centers.... Seventy-one participants (20 subacute stroke, 20 chronic stroke, 31 controls) were recruited (N=71).... Muscle mechanical properties were measured bilaterally with a MyotonPRO at muscle belly and musculotendinous sites during 2 protocols (muscle relaxed or in maximal bearable stretched position).... Muscle tone and stiffness of the biceps brachii and gastrocnemius. Poststroke spasticity was evaluated with the Modified Tardieu Scale (MTS). A mixed-model analysis of variance was used to detect diff... The analysis of variance showed a significant effect of muscle position on muscle mechanical properties (higher tone and stiffness with the muscle assessed in stretched position). Measurements with th... Myotonometry assessment of mechanical properties with the muscle stretched improves the ability of myotonometry to discriminate between sides in patients after stroke and between people with and witho...

Humans Muscle Spasticity Cross-Sectional Studies Stroke Muscle, Skeletal +2 autres

Ultrasound findings in painful spastic hip. Muscle thickness in children with cerebral palsy.

22 Jun 2023

DOI: 10.1186/s12891-023-06610-8 PMID: 37349815

In cerebral palsy (CP), spasticity is the dominant symptom and hip pain is one of the most common secondary conditions. Aetiology is not clear. Musculoskeletal ultrasound (MSUS) is a low-cost, non-inv... A retrospective case-matched-control study. To investigate associated factors with painful spastic hip and to compare ultrasound findings (focusing on muscle thickness) in children with CP vs. typical... Paediatric Rehabilitation Hospital in Mexico City, from August to November 2018.... 21 children (13 male, 7 + 4.26 years) with CP, in Gross Motor Function Classification System (GMFCS) levels IV to V, with spastic hip diagnosis (cases) and 21 children age- and sex-matched (7 + 4.28 y... Sociodemographic data, CP topography, degree of spasticity, mobility arch, contractures, Visual Analog Scale (VAS), GMFCS, measurements of the volumes of eight major muscles of the hip joint and MSUS ... All children with CP group reported chronic hip pain. Associated factors for hip pain (high VAS hip pain score) were degree of hip displacement (percentage of migration), Ashworth Level, GMFCS level V... Though possibly the most important issue with diminished muscle growth in CP children is the influence on their long-term function, it is likely that training routines that build muscle size may also ...

Child Humans Male Muscle Spasticity Retrospective Studies +3 autres

The Effect of Botulinum Neurotoxin-A (BoNT-A) on Muscle Strength in Adult-Onset Neurological Conditions with Focal Muscle Spasticity: A Systematic Review.

08 Aug 2024

DOI: 10.3390/toxins16080347 PMID: 39195757

Botulinum neurotoxin-A (BoNT-A) injections are effective for focal spasticity. However, the impact on muscle strength is not established. This study aimed to investigate the effect of BoNT-A injection...

Humans Muscle Spasticity Botulinum Toxins, Type A Muscle Strength Neuromuscular Agents +3 autres

The effects of gastrocnemius muscle spasticity on gait symmetry and trunk control in chronic stroke patients.

09 2023

DOI: 10.1016/j.gaitpost.2023.07.004 PMID: 37480819

Although reduced gait asymmetry and trunk control are generally accepted outcomes in stroke patients after having a stroke, the number of studies examining the factors affecting gait symmetry and trun... What are the effects of gastrocnemius muscle spasticity on trunk control and gait symmetry in chronic stroke patients?... The sample of the study included 29 individuals aged 40-70 who were diagnosed with stroke at least six months ago. The sociodemographic information of the patients was collected using a descriptive in... There was a numerical difference between the gait symmetry results of the patients who had a MAS score lower than 2 and those who had a MAS score of 2 or higher, where MAS scores corresponded to gastr... According to the results of our study, to improve trunk control and gait in stroke survivors, the management of gastrocnemius muscle spasticity should be included in rehabilitation programs. We believ...

Humans Muscle Spasticity Gait Patients Stroke +1 autres

Effects of neurorehabilitation with and without dry needling technique on muscle thickness, reflex torque, spasticity and functional performance in chronic ischemic stroke patients with spastic upper extremity muscles: a blinded randomized sham-controlled clinical trial.

Mar 2024

DOI: 10.1080/09638288.2023.2190168 PMID: 36970837

Evaluation the effects of dry needling on sonographic, biomechanical and functional parameters of spastic upper extremity muscles.... Twenty-four patients (35-65 years) with spastic hand were randomly allocated into two equal groups: intervention and sham-controlled groups. The treatment protocol was 12-sessions neurorehabilitation ... The analysis showed that there was a significant reduction in muscle thickness, spasticity and reflex torque and a significant increment in motor function and dexterity in both groups after treatment ... Dry needling plus neurorehabilitation could decrease muscle thickness, spasticity and reflex torque and improve upper-extremity motor performance and dexterity in chronic stroke patients. These change...

Humans Muscle Spasticity Ischemic Stroke Percutaneous Collagen Induction Torque +8 autres

Coronaviridae : Questions médicales fréquentes

Termes MeSH sélectionnés :

Questions fréquentes et termes MeSH associés

Diagnostic 5

Symptômes 5

Prévention 5

Traitements 5

Complications 5

Facteurs de risque 5

Contenu validé par Dr Olivier Menir

Sous-catégories

Coronavirus

Torovirus

Alphacoronavirus

Betacoronavirus

Deltacoronavirus (genre)

Gammacoronavirus

Alphacoronavirus-1

Coronavirus humain 229E

Coronavirus humain NL63

Virus de la diarrhée porcine épidémique

Betacoronavirus-1

Coronavirus du rat

Coronavirus du syndrome respiratoire du Moyen-Orient

Virus de l'hépatite murine

Virus du SRAS

Coronavirus de la dinde

Virus de la bronchite infectieuse

Coronavirus canin

Coronavirus félin

Virus de la gastroentérite transmissible

Coronavirus humain OC43

Coronavirus bovin

SARS-CoV-2

Coronavirus respiratoire porcin

Auteurs principaux

Sources (10000 au total)